Unique fixed position
Cast financing whole technological process to analyse project road to perform actual combat drilling
,
Frame program
The first edition piece: Flow element invests mode
The theme makes a speech: Different investment pattern is analysed
Ni Bin sunshine copartner of operation of capital of vessel abundant unripe division
Experience of industry of medical treatment of 23+ years of United States, Singapore, China, dedicated at biology technology investment is run. Below the setting of diversity, he accumulated business affairs of research and development of industrial group medicaments, BD to extend, the compound experience that venture capital investment, business grows. Ceng Jianli surpasses the exterior innovation group that Nuofeidi covers Asia-Pacific area, professional work of successful development trades cooperative strategy, ever also was in company of 500 strong Medical Protection holds the position of famous fortune advanced science and administrative position, include a ceremony to come to a company (general manager of division of big China of Action Group) , Covance () Shi Ke of He Gelan element (nerve retreats) of director of center of travel sex disease.
Thematic speech: ? Crouch receive crash to stop is of M of ÷ of stalk of exuviate of formic Piao excessive treated?
President of capital of Yang Yunxia Chinese larch
Dedicated the investment at domain of medical treatment health, dominant finished medical treatment health the project of many fractionize industry invests, ever health of medical treatment of capital of inaugural gentleman couplet invests a group, the United States is born by force, the large transnational corporation such as GE. Investment of Chinese larch capital includes cornerstone drug industry, happy event too health, China biology of big gene, new industry... wait for an enterprise.
Round-table interview: The appraise value of innovation enterprise and group equity framework
Interview honored guest: Ni Bin sunshine Chen Penghui of of Tang Yan of Yang Yunxia Yu Guoliang
Fund of far medical treatment of Chenpeng brightness rich is virgin copartner
Founding Bo Yuan holds the position of partner of fund of China of Chinese larch capital before medical treatment fund, be in charge of the investment of medical treatment domain. Yu Guang holds a post to accuse greatly before, established light to accuse greatly head period medical treatment fund, hold the position of fund chief, be in charge of the management of fund and investment in the round.
Because of,representative investment project includes Hua Daji (300676) , zhejiang shellfish amounts to medicine (300558) , fish dive medical treatment (SZ002223) , again vessel medicine (Nasdaq ZLAB) , the appropriate in the United States and, the lead company of the domain of medical treatment of nearly 20 home such as registration net.
The second edition piece: Business affairs negotiation appears on the market with exit
The theme makes a speech: Appear on the market to think with what exit: A, harbor, how is the US stock chosen?
President of company of pharmacy of beautiful rich of division of Yu Guoliang coronal
Scholar + the person that do poineering work + the multiple identity of investor, in Sino-US do poineering work old and rich experience is had in the different perspective with investment, the angel investor of company of 20 healthy estates, the venture partner of abstruse rich capital, developed large quantities of CEO level person with abilities. Founded company of technology of nearly 10 biology to hold the position of president jointly, have much home company to appear on the market successfully the experience that exit -- the Epitomics company that establish is appeared on the market by England with 170 million dollar the company is bought. The make up the deficits and get surpluses after joining Sino-US coronal division appears on the market successfully to be bought in order to make an appointment with 2.64 billion RMB by JSR, be aimed at home of entrepreneur, investment to undertake sharing schoolteaching in college and the platform such as Stanford university, muddleheaded university for many times.
The theme makes a speech: How to lead poineering group to hold financing and outspread rhythm many rounds
Liu Weimin this path capital copartner
Rich experience of more than 20 years is had in medicine and domain of biology science and technology. Ever assumed office to extend a branch at the business of company of several pharmacy that cross a state, include to hold the position of Shi Ke of arrowroot orchid element (GSK) the global person in charge that nerve science business extends a branch, and silent overcomes China (Merck KGaA) innovate external Chinese director of the branch. Ever was in as scientist Dr. Liu work of field of medicaments research and development exceeds 10 years.
The theme makes a speech: The communication of investor and scientist is artistic
Zhang Yuyi holds biology general manager high
The source in Ceng Ren assist with expert of program of strategy of Inc. of cellular gene project, president assistant, be participated in and investment of strategy of responsible estate fund and Sino-US and as joint-stock as actor luck division negotiation, at present comprehensive and responsible cheek holds biology high to specialize in CAR-T to treat hypostatic tumour field.
Hot! Scene show performs: Investment trades scene of business affairs negotiation is beautiful
The adviser is round: Bin of Ni of Zhang Yu of Liu Weimin of good people of more than country sunshine
The 3rd edition piece: Industry of law politics new rule is combed
Round-table interview: Below change of medical prison policy, the good luck that focusing medical treatment invests and challenge
Interview honored guest: Wang Liqun of Zheng Yufen of Tang Yan
The theme makes a speech: Dig cellular immunity greatly to treat track
Wang Liqun Fu Xingkai is special president
In the beauty biology pharmacy domain accumulated substantial professional knowledge and experience of management of research and development, clean of Ceng Zaimei national treasure, 100 when beautiful Shi Guibao, and the center of research and development that Asilikang and Shi Ke of Ge Lan element are in China is held the position of main item and. The administrative manager such as construction of the deep understanding that has pair of cell immunity to treat a trade and strategic collaboration, group.
The theme makes a speech: 2018 year gene detects industry analysis
Zheng Yufen imprints about medical treatment fund manages partner
Have old industry experience and dominant finished many purposes inside course of study to cast financing, accumulative total trades the forehead is close 2 billion yuan of RMBs. Ever Ren Qiming is achieved cast medical treatment health to invest copartner of capital of chief inspector, clear division. Have Tsinghua university economy to run academic master's degree.
Investment case: Beijing luck China, attain extensive is science and technology of subsidiary channels in the human body through which vital energy, parturient small dispatch of gene, cure (guest of Liu Xie knife) , healthy bound, with weather medical service canal, an ancient type of banner hoisted on a featherdecked mast allows division of medical treatment, day cure of elegant, name advocate Kang Guobin of knife, love, Yakangbo.
The theme makes a speech: A collection of illustrative plates of look forward to of churchyard innovation medicine is combed
Summary: Industry of drug of 100 aid China, cornerstone, Kangningjierui, letter is amounted to, song ceremony, China get, inferior fill industry of medicine, development drug...
Tang Yan is opened bright achieve investment partner
2002 - promoted in morning 2015 achieve cast make biology medicine investment, hold the post of Beijing office general manager. Invest companies of tens of domestic biology medicine independently, hold the post of director of much home company, deepness participates in the management after casting and project to exit. The medicaments that Ge Lan holds a post to element history controls medical company and have 7 years before joining morning to promote registers experience, medicines and chemical reagents of provision of perfectness China state controls management board (the medicines and chemical reagents of SFDA) and medical apparatus and instruments are declared examine and approve management, have rich medicine to examine and approve the working experience that registers a respect and relation of person arteries and veins.
The 4th edition piece: The strategy reveals project road to act
The strategy reveals: How deepness understanding gene detects trade current situation and formulate operation strategy
Float essence of parturient focusing cancer allows medical treatment, product and service enclothe cancer full cycle (the risk is evaluated, inchoate sieve is checked, molecular pathology is diagnosed, the guidance that use drug and prognosis are monitored) , for crowd of crowd of cancer patient, tall danger and health, and cancer is relevant domain investigator, the molecular diagnosis and treatment that provides scientific major and scientific research serve a solution.
Hong Ying floats COO of parturient gene science and technology
Have the market operation that healthy domain exceeds medical treatment 16 years and administrative experience, have successively held the posts of general manager of division of China of American Bader medical treatment and boreal subregion vice-president (Bader is one of companies of the world's lead the medical apparatus and instruments that cross a state, the product covers surgical, tumour, Fu to produce, the domain such as vivid check and secrete make water) , chief inspector of market of region of Asia-Pacific of strong unripe medical treatment and inspector general of surgical department of strong unripe China.
Project road develops:
(it is as follows can make public a project, the detail consults meeting Wu group please)
Children health manages tall nicety to detect equipment and system
Financing annulus second: Amount of A annulus financing: Of short duration is not announced
Spokesman: General manager of limited company of science and technology of tall medical treatment of shellfish of Hong Chuan Shanghai
The fiber that fight lung turns project of research and development of polypeptide innovation drug
Financing annulus second: Amount of A annulus financing: 9 million dollar
Spokesman: Li Xiaomei becomes vise general manager of limited company of medicine of Dou Huitai biology
Brief introduction: Chengdu benefit peaceful changes the crucial signal access that happen in the light of fiber, developed a kind of polypeptide and its ramification independently, first get used to disease to be changed for lobar fiber, fiber changes block to decide medical effect remarkable, security is good.
Assistance unit
The way develops recruit
(only remnant 1 banquet)
Charge signing up:
20 thousand yuan / banquet
(contain 2 to join meeting quota of people)
Transmit privilege:
Business person or investment public figure, be like you
In friend circle and a major group at the same time transmit this article, and check scheme sends meeting Wu group Xiaoyi (the graph below scanning 2 dimension are piled up) .
Charge signing up but derate 2000 yuan!
(the newspaper ends completely, all explanation authority puts in meeting Wu group 's charge all)
(small signal of Xiaoyi of meeting Wu group)
Sign up seek advice:
Mobile phone: 185 1629 3586
Register directly:
Support media
